Thermo Fisher (TMO) is close to a deal for Solventum’s (SOLV) purification and filtration business, The Wall Street Journal’s Lauren Thomas reports. A transaction, which could be announced as soon as this week, is expected to value the filtration business between $3.5B-$4B, according to people familiar with the matter.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher files automatic mixed securities shelf
- Thermo Fisher Expands Board with Healthcare Executive
- Thermo Fisher raises quarterly dividend 10% to 43c per share
- Third Point buys Capital One, cuts Microsoft in Q4
- Trump Trade: President to impose 25% tariffs on steel, aluminum imports